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The molecular hallmarks of ATL comprise outstanding
deregulations of signaling pathways that control cell cycle,
apoptosis resistance, and proliferation of leukemic cells.
Using integrative analyses of primary ATL cells, we dis-
covered unique molecular characteristics of ATL (Yama-
gishi et al., Cancer Cell, 2012). Genetic and epigenetic
disruption leads to numerous gene expression alterations
that dominate disorders of homeostasis and characteristics
of ATL. In particular, a novel tumor suppressor miR-31 is
completely lost in all ATL cases, leading to constitutive
NF-kB activation via NIK overexpression. Polycomb family
directly involves in the silencing of miR-31, providing a
novel interconnection between epigenetic reprogramming
and NF-kB pathway. In addition, we recently unveiled
molecular mechanisms how Polycomb-dependent epige-
netic perturbation is abnormally sustained in HTLV-1
infected and leukemic cells. We discuss the recent discov-
ery of molecular hallmarks of potential generality, an
abnormal miRNA pattern and epigenetic reprogramming,
which strongly involve the imbalance of the molecular
network of lymphocytes. Because epigenetic marks are
potentially reversible, development of genuine epigenetic-
targeted therapy drugs holds great promise in HTLV-1-
related diseases. Furthermore, we also introduce additional
signaling pathways affecting leukemic cell fate. Pathway
analysis based on our comprehensive dataset and biologi-
cal studies suggest breaking down of the essential signaling
pathways such as Hedgehog and p38 pathways, which sup-
port the biological properties of ATL. Because these
organized principles may be directly associated with the
clinical traits of ATL, targeting the one outstanding hall-
mark or co-targeting of multiple molecular hallmarks in
mechanism-guided combinations will result in more effec-
tive and durable therapies for aggressive ATL.
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